Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion

AIMS: Myopathy or neuropathy has been associated with lamivudine/telbivudine therapy in hepatitis B patients. We aim to describe the pathological changes of lamivudine/telbivudine-associated neuromyopathy. METHODS: We retrospectively recruited six patients who were diagnosed with nucleotide analogue...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hongliang, Wang, Zhaoxia, Zheng, Lemin, Zhang, Wei, Lv, He, Jin, Suqin, Yuan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215273/
https://www.ncbi.nlm.nih.gov/pubmed/25190818
http://dx.doi.org/10.1136/jclinpath-2013-202069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215273/
https://www.ncbi.nlm.nih.gov/pubmed/25190818
http://dx.doi.org/10.1136/jclinpath-2013-202069

Ejemplares similares